Indiva Limited (NDVAF) Stock Price & Growth Analysis

Quote Panel

Updated October 18, 2025

1W % 1M % 3M % 1Y -0.24 %

Key Metrics

Market Cap
4.60M
Shares Outstanding
206.34M
Share in Float
145.89M
Dividende
0

Earning Date
No Data
Price Target
0.0223
Average Volume
13467
Beta
0.584

Range
0.021-0.0233
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.indiva.com
Sector
Healthcare

Quote Panel

Updated October 18, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.17x

P/S Ratio

N/Ax

P/B Ratio

N/A

Debt/Equity

-13.1%

Net Margin

$-0.0

EPS

How NDVAF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

NDVAF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

NDVAF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$49M

425%

2025-Revenue

N/A

2025-EPS

$24M

-4467%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.21

N/A

-0.03
vs NA

Q1.22

N/A

-0.02
vs NA

Q2.22

N/A

-0.02
vs -0.01

Q3.22

N/A

-0.02
vs -0.05

Q4.22

N/A

-0.02
vs -0.03

Q1.23

N/A

-0.02
vs -0.02

Q2.23

N/A

-0.01
vs -0.02

Q3.23

N/A

-0.00
vs -0.02

Q4.23

N/A

NA
vs -0.02

Q1.24

N/A

-0.01
vs -0.02

Sales Growth

YoY

Current

Estimates

Q2.22

-10%

8.1M vs 9.1M

Q3.22

+5%

8.1M vs 7.7M

Q4.22

-2%

9.3M vs 9.5M

Q1.23

+5%

9.4M vs 8.9M

Q2.23

-8%

7.5M vs 8.1M

Q3.23

+21%

9.8M vs 8.1M

Q4.23

+17%

10.9M vs 9.3M

Q1.24

-1%

9.3M vs 9.4M

Q2.24

+38%

10.4M vs 7.5M

Q3.24

+15%

11.2M vs 9.8M

Return on Equity

QoQ

Q4.21

-34%

-0.34
vs -0.50

Q1.22

-33%

-0.33
vs -0.34

Q2.22

-37%

-0.37
vs -0.33

Q3.22

-58%

-0.58
vs -0.37

Q4.22

-130%

-1.30
vs -0.58

Q1.23

+6690%

66.9
vs -1.30

Q2.23

-80%

-0.80
vs 66.9

Q3.23

-243%

-2.43
vs -0.80

Q4.23

+224%

2.24
vs -2.43

Q1.24

+138%

1.38
vs 2.24

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q4.21

N/A

-0.03
vs NA

Q1.22

N/A

-0.02
vs NA

Q2.22

N/A

-0.02
vs -0.01

Q3.22

N/A

-0.02
vs -0.05

Q4.22

N/A

-0.02
vs -0.03

Q1.23

N/A

-0.02
vs -0.02

Q2.23

N/A

-0.01
vs -0.02

Q3.23

N/A

-0.00
vs -0.02

Q4.23

N/A

NA
vs -0.02

Q1.24

N/A

-0.01
vs -0.02

Sales Growth

YoY

Current

Estimates

Q2.22

-10%

8.1M vs 9.1M

Q3.22

+5%

8.1M vs 7.7M

Q4.22

-2%

9.3M vs 9.5M

Q1.23

+5%

9.4M vs 8.9M

Q2.23

-8%

7.5M vs 8.1M

Q3.23

+21%

9.8M vs 8.1M

Q4.23

+17%

10.9M vs 9.3M

Q1.24

-1%

9.3M vs 9.4M

Q2.24

+38%

10.4M vs 7.5M

Q3.24

+15%

11.2M vs 9.8M

Return on Equity

QoQ

Q4.21

-34%

-0.34
vs -0.50

Q1.22

-33%

-0.33
vs -0.34

Q2.22

-37%

-0.37
vs -0.33

Q3.22

-58%

-0.58
vs -0.37

Q4.22

-130%

-1.30
vs -0.58

Q1.23

+6690%

66.9
vs -1.30

Q2.23

-80%

-0.80
vs 66.9

Q3.23

-243%

-2.43
vs -0.80

Q4.23

+224%

2.24
vs -2.43

Q1.24

+138%

1.38
vs 2.24

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

0.02USD

N/A

0.17x

N/Ax

N/A

-13.1%

$-0.0

$49M

N/A

$24M

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

$49M

N/A

$24M

Company Description

0.02USD

N/A

0.17x

N/Ax

N/A

-13.1%

$-0.0